




Searching News Database: AVANIR Pharmaceuticals
HSMN NewsFeed - 7 Nov 2019
Neurana Pharmaceuticals Appoints Randall Kaye, M.D., Chief Medical Officer
Neurana Pharmaceuticals Appoints Randall Kaye, M.D., Chief Medical Officer
HSMN NewsFeed - 11 Dec 2018
Avanir Pharmaceuticals Announces Termination of License Agreement with Optinose for ONZETRA(R) Xsail(R)
Avanir Pharmaceuticals Announces Termination of License Agreement with Optinose for ONZETRA(R) Xsail(R)
HSMN NewsFeed - 25 Oct 2018
89Bio Launches into Liver and Metabolic Disorders with $60 Million Series A Financing
89Bio Launches into Liver and Metabolic Disorders with $60 Million Series A Financing
HSMN NewsFeed - 30 Nov 2015
OticPharma Appoints Keith A. Katkin as Chairman of the Board of Directors
OticPharma Appoints Keith A. Katkin as Chairman of the Board of Directors
HSMN NewsFeed - 27 Oct 2015
CoLucid Pharmaceuticals Announces Election of Mark Corrigan, M.D., to Board of Directors
CoLucid Pharmaceuticals Announces Election of Mark Corrigan, M.D., to Board of Directors
HSMN NewsFeed - 2 Dec 2014
Avanir Pharmaceuticals To Be Acquired By Otsuka Pharmaceutical For $3.5 Billion
Avanir Pharmaceuticals To Be Acquired By Otsuka Pharmaceutical For $3.5 Billion
HSMN NewsFeed - 2 Dec 2013
Visterra Closes $8.1 Million Financing and Expands Executive Team to Accelerate Company Growth
Visterra Closes $8.1 Million Financing and Expands Executive Team to Accelerate Company Growth
HSMN NewsFeed - 6 Sep 2013
Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Wockhardt
Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Wockhardt
HSMN NewsFeed - 3 Sep 2013
Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Actavis
Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Actavis
HSMN NewsFeed - 14 Aug 2013
Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Sandoz
Avanir Pharmaceuticals Announces Settlement of NUEDEXTA Patent Litigation with Sandoz
HSMN NewsFeed - 16 Mar 2012
Avanir Pharmaceuticals Announces Appointment of Rohan Palekar as Chief Commercial Officer
Avanir Pharmaceuticals Announces Appointment of Rohan Palekar as Chief Commercial Officer
HSMN NewsFeed - 11 Apr 2011
Avanir Pharmaceuticals Announces Appointment of William Sibold as Chief Commercial Officer
Avanir Pharmaceuticals Announces Appointment of William Sibold as Chief Commercial Officer
HSMN NewsFeed - 17 Feb 2011
AVANIR Pharmaceuticals Appoints Gregory J. Flesher to Senior Vice President and Chief Business Officer
AVANIR Pharmaceuticals Appoints Gregory J. Flesher to Senior Vice President and Chief Business Officer
HSMN NewsFeed - 31 Jan 2011
AVANIR Pharmaceuticals Announces U.S. Launch and Availability of NUEDEXTA for Pseudobulbar Affect
AVANIR Pharmaceuticals Announces U.S. Launch and Availability of NUEDEXTA for Pseudobulbar Affect
HSMN NewsFeed - 3 Jul 2007
Azur Pharma Announces the Acquisition of FazaClo for $42 Million Plus Contingent Milestones
Azur Pharma Announces the Acquisition of FazaClo for $42 Million Plus Contingent Milestones
HSMN NewsFeed - 18 Apr 2007
Avanir Pharmaceuticals Announces Positive Results of Phase III Study for Zenvia in Diabetic Neuropathic Pain
Avanir Pharmaceuticals Announces Positive Results of Phase III Study for Zenvia in Diabetic Neuropathic Pain
HSMN NewsFeed - 3 Apr 2007
Amarin Appoints Paul F. Duffy to New Position of President - U.S. Commercial Operations
Amarin Appoints Paul F. Duffy to New Position of President - U.S. Commercial Operations
HSMN NewsFeed - 30 Jan 2007
AVANIR Receives FDA Approvable Letter for New Formulation of Currently Marketed Antipsychotic Drug FazaClo
AVANIR Receives FDA Approvable Letter for New Formulation of Currently Marketed Antipsychotic Drug FazaClo
HSMN NewsFeed - 16 Jan 2007
Harold F. Oberkfell Succeeds Steven A. Elms as Chairman of Adams Respiratory Therapeutics
Harold F. Oberkfell Succeeds Steven A. Elms as Chairman of Adams Respiratory Therapeutics
Additional items found! 15

Members Archive contains
15 additional stories matching:
AVANIR Pharmaceuticals
(Password required)
AVANIR Pharmaceuticals
(Password required)